1. Home
  2. MEC vs RLMD Comparison

MEC vs RLMD Comparison

Compare MEC & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mayville Engineering Company Inc.

MEC

Mayville Engineering Company Inc.

HOLD

Current Price

$26.55

Market Cap

654.4M

Sector

Industrials

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$5.30

Market Cap

524.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEC
RLMD
Founded
1945
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
654.4M
524.9M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
MEC
RLMD
Price
$26.55
$5.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$24.33
$12.40
AVG Volume (30 Days)
501.1K
1.6M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.28
EPS
N/A
N/A
Revenue
N/A
$13,070.00
Revenue This Year
$10.65
N/A
Revenue Next Year
$8.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
154.83
52 Week Low
$12.10
$0.55
52 Week High
$38.76
$8.00

Technical Indicators

Market Signals
Indicator
MEC
RLMD
Relative Strength Index (RSI) 31.88 35.69
Support Level $16.56 $4.85
Resistance Level $28.00 $7.28
Average True Range (ATR) 2.15 0.39
MACD -0.70 0.01
Stochastic Oscillator 9.85 19.50

Price Performance

Historical Comparison
MEC
RLMD

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly, and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, powersports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly, and logistic services.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: